Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FUDR/Oxaliplatin HAI Plus Irinotecan vs FOLFOXIRI in Unresectable CRCLM
NCT03678428Phase 3Terminated
- Sponsor
- Sun Yat-sen University
- Start
- Dec 2021
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of floxuridine in Colorectal cancer with liver metastases (CRLM), sponsored by Sun Yat-sen University. Started Dec 2021; status: terminated.
02
Drugs
floxuridine
03
Conditions
Colorectal cancer with liver metastases (CRLM)
Beyond the preview
Go deeper on NCT03678428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03678428.